ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 221 GBX 0.82% Market Closed
Market Cap: 4.5B GBX
Have any thoughts about
ConvaTec Group PLC?
Write Note

ConvaTec Group PLC
Investor Relations

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands.

ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Karim Bitar
CEO & Director
No Bio Available
Mr. Jonathan Peter Mason
Group CFO & Director
No Bio Available
Mr. John Haller
Executive VP and Chief Quality & Operations Officer
No Bio Available
Dr. Divakar Ramakrishnan Ph.D.
Executive VP, Chief Technology Officer and Head of Research & Development
No Bio Available
Ms. Kate Postans
Vice President of Investor Relations & Corporate Communications
No Bio Available
Ms. Evelyn Douglas J.D.
Executive VP, Chief of Corporate Strategy & Business Development and General Counsel
No Bio Available
Ms. Moyra Withycombe
Interim Chief People Officer
No Bio Available
Ms. Kjersti Grimsrud Biotechnology, M.Sc.
President & COO of Infusion Care
No Bio Available
Mr. David Shepherd
President & COO of Global Advanced Wound Care
No Bio Available
Mr. Seth R. Segel
President and COO of Continence Care & Home Services Group
No Bio Available

Contacts

Address
BERKSHIRE
Reading
Fl 7, 3 Forbury Place, 23 Forbury Road
Contacts